Preoperative Anxiety and Surgical Fear in Holmium Laser Enucleation of the Prostate and Transurethral Resection of the Prostate Patients With Benign Prostatic Hyperplasia

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age50+
SponsorHitit University

About this trial

Benign prostatic hyperplasia (BPH) is a common condition in older men and may cause bothersome lower urinary tract symptoms that can negatively affect quality of life. Surgical treatment with Holmium Laser Enucleation of the Prostate (HoLEP) or Transurethral Resection of the Prostate (TURP) is often recommended when medical therapy is insufficient.

This prospective observational study aims to evaluate whether preoperative anxiety, depression, and surgical fear influence postoperative functional outcomes, urinary continence, erectile function, and patient satisfaction in patients undergoing HoLEP or TURP for BPH. Participants will complete validated psychological and functional questionnaires before surgery and during postoperative follow-up visits at 1 and 3 months. The study will also assess changes in psychological status after surgery and compare outcomes between HoLEP and TURP patients.

The findings may help improve preoperative patient counseling and identify patients who could benefit from additional psychological support before surgery.

Eligibility criteria

Qualifiers

Male patients aged 50 years or older

Diagnosis of benign prostatic hyperplasia (BPH)

Scheduled to undergo HoLEP or TURP

Ability to understand and complete study questionnaires

Disqualifiers

History of severe psychiatric disorder

Active psychiatric treatment

Neurogenic bladder or neurologic voiding dysfunction

Diagnosis of prostate cancer

Trial design

Treatments tested in this trial

  • Holmium Laser Enucleation of the Prostate (HoLEP)
  • Transurethral Resection of the Prostate (TURP)

Treatment groups

80 Participants
are divided into 2 treatment groups

Sponsors and collaborators